Member Info for 0161

Covid aside it looks like a good time to be invested in UK pharma, as the UK is focusing on accelerating the life sciences industry.

https://www.ft.com/content/424ad1e2-9984-4e10-9ffa-0ed08f4e598b

The article is from the Washington Post

https://www.google.com/amp/s/www.washingtonpost.com/politics/2020/12/10/daily-202-giuliani-released-hospital-after-getting-coronavirus-treatments-many-are-dying-without/%3foutputType=amp

The Article is suggesting that monclonal antibodies DO successfully treat covid, and it's being kept for the elite and their friends.

“The minute I took the ****tail yesterday, I felt 100 percent better,” Giuliani said in a Tuesday afternoon interview with WABC, a New York talk radio station. “It works very quickly. Wow! … By the next morning, I felt like I was 10 years younger.”

Ohh what a life it must be separating the wheat from the chaff, if you catch my drift - hehe

Joke at the end should have read it would be Cexaminer that would be wanting to read the safety certificate before getting in the lifeboat.

Never a good joke when you need to correct, sorry

Davey, did a SARS vaccine get FDA approval ? What year was this I am struggling to find the details?

"it should be remembered that is is not an entirely new vaccine, it is a modified version of a SARS vaccine that has been proven to be entirely safe."

There is always an element of risk, but love the lifeboat to put things in to context, ship sinking and your really want to check the safety certificate of the lifeboat just in case hahaha, probably would be one, and it would probably be examined.

Nasdaq price is pushing on upwards towards the equivalent of £1 today.

Crazy how we followed it down, let's see if we follow it up tomorrow or if the gap opens up again.

SK with your Twitter troll, screenshot his post and send it back to him in 3 months. Not sure he will be quite we happy with himself.

The last time we was in the price range we were all happy and convinced of a quick re-rate.
Price tripped but slide back down despite the fundamentals improving.

Now we at this price with
> An extra £50 million in the bank.
> Only weeks away from result news of our blockbuster drug after its been fast tracked faster than we could have imagined.
> A huge extra market for the drug, and very positive that the UK gov have placed an order for a similar drug that is also in the testing phase.
> Main market listing pending
> Accustem now separate and is going to be generating revenue very soon, and can also be easily sold.

Earlier in the year we was all happy with 90p without any of that ^ because we knew the potential, we still have all of that potential plus are in a much better position and closer than ever to unlocking revenue steams.

I know its disappointing as we have already tasted higher prices, but for me its not blind faith, this company is more likely than most to more than triple. Revenue is closer than its ever been, as a few have said the strange trading could be due to a buyout, but regardless of that this really could rocket in no time. Its a much better prospect than it was when it was previously 90p and we rightly thought it was a bargain then.

What monoclonal antibodies are – and why we need them as well as a vaccine

https://www.google.com/amp/s/theconversation.com/amp/what-monoclonal-antibodies-are-and-why-we-need-them-as-well-as-a-vaccine-149356

An awful lot of noise on mabs treating covid while the market have been closed. This should be an interesting week while we are waiting for the Brazil trial results.

https://www.google.com/amp/s/www.cbc.ca/amp/1.5811763

On sky news TV now

Imagine what an order half that size would do to the Tiziana share price on open.

https://www.google.com/amp/s/news.sky.com/story/amp/covid-19-uk-volunteer-first-in-the-world-to-trial-coronavirus-antibody-treatment-12137777

Sky News are about to run the story of AZ monoclonal.

Also I think there is news that the UK gov have placed an order for 1m doses if it passes P3 trial.

Now is the time for therapeutics and monclonal antibodies looks to be top of the list.

Also picked up by the mail and sun.

https://www.dailymail.co.uk/news/article-8972013/amp/Trials-AstraZeneca-s-new-Covid-19-antibody-treatment-set-begin-UK.html

I think this could be a very important moment for our short term share price. There is a lot to say that mabs are the most promising therapeutic for covid.
The world's attention has been taken by vaccines but to see it now focus strongly back on monclonal antibodies is excellent news for Tiziana, certainly gives more confidence that the Brazil trials could be a pivotal moment on this share price.

After the battering the share price took when the vaccine news broke, this could be much more pivitol in the upwards direction. Gla

Attempt 3, LSE is filtering a word in the link, hopefully this gets around that.

https://rb.gy/pdikhl

Sorry I don't think the link was correct, here you go

https://www.lbc.co.uk/news/uk-first-to-trial-astrazeneca-antibody-****tail-aimed-at-non-vaccine-patients/

Interesting, are we now seeing the focus moving to treatments rather than vaccines.

https://amp-lbc-co-uk.cdn.ampproject.org/c/s/amp.lbc.co.uk/news/uk-first-to-trial-astrazeneca-antibody-****tail-aimed-at-non-vaccine-patients/?utm_source=upday&utm_medium=referral

Don't want to be too rampy or jinx it, but the climb this week is very encouraging imo.

The last time we had a sustained strong period of upward pressure like this was the 8th Oct when the share price increased over 60p in just a few days.

Given that this week's upturn hasn't really come from news it looks like it's gapping up the the Nasdaq price nicely.

What is the mood here on LSE for the share price expectations by the start of December ?
£1.40 range for me

I find that statement a bit self important, and is probably the reason why a fair few people are calling you out for having an agenda.

Your experience might have brought you to YOUR negative conclusions. But to dismiss the vast majority which see huge upside in this share, as emotional rather than knowledgeable exposes you a bit here.

I think it is just as valid to say the vast experiences of the masses who are well researched and excited can't be dismissed as emotion simply based on your own personal knowledge and or agenda.

Good luck with your investment and I hope that your knowledge and experience pay off for you, but let's not dismiss others if it doesn't fit.